Assignee
ALLIFE MEDICINE BEIJING LTD
CN·1 granted patent·4 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
5 records- 0146US2024207316A1Chimeric receptor for improving killing activity of immune cells and application thereofALLIFE MEDICINE BEIJING LTD·Filed 2023·Application pending·0 cites
- 0244US2025049847A1A method for inducing ipsc differentiation to obtain cd34+cells and nk cells and application thereofALLIFE MEDICINE BEIJING LTD·Filed 2022·Application pending·0 cites
- 0344US2024247230A1Application of genetically modified oligodendrocyte progenitor cells in multiple sclerosisALLIFE MEDICINE BEIJING LTD·Filed 2024·Application pending·0 cites
- 0432US12398370B2Culture medium and method for inducing iPSC differentiation to obtain macrophages and use thereofALLIFE MEDICINE BEIJING LTD·Filed 2025·Granted Aug 26, 2025·0 cites·3 claims
- 0532US2025250543A1Methods for preparing mesenchymal stem cellsALLIFE MEDICINE BEIJING LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ALLIFE MEDICINE BEIJING LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →